Inonda - 8mg, Injection, 4 ml

₹ 34.69/Piece

Strength8 mg/4ml
Pack size4 ml
BrandInonda 8mg
Pack typeAmpoule
RouteIV IM
Packaging TypeBox
ManufacturerOscar Remedies
Shelf Life24 months
Dosage formInjection
CompositionOndansetron
AvailabilityIn Stock
Ondansetron is an antiemetic medication. It works by blocking the action of a chemical messenger (serotonin) in the brain that may cause nausea and vomiting during anti-cancer treatment (chemotherapy) or after surgery.

Find products similar to Inonda - 8mg, Injection, 4 Ml

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNew Delhi
ShippingAs per delivery location

Product Image

Inonda - 8mg, Injection, 4 ml image 1Inonda - 8mg, Injection, 4 ml image 2Inonda - 8mg, Injection, 4 ml image 3Inonda - 8mg, Injection, 4 ml image 4Inonda - 8mg, Injection, 4 ml image 5

About the Company

GST Registration Date
Feb 2019
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
51 To 100 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
July 2013
GST
07**********1ZM
Import Export Code (IEC)
*******21F

Akcent Healthcare was founded out of passion in the year 2019, based in the heart of India (Delhi) the capital of India by our founders to be more than a business firm that aims at profit. However, it actively started working as a fully integrated pharmaceutical company in 2019z. Today, we have more than 100 products and are heading towards a turnover of 200 million. Our primary center lies in creating the finest quality item. We have a very long list which incorporates items such as Softgels, Capsules, Tablets, Protein Powder, Syrups Antibiotics, etc.
India's most upcoming & fastest growing Pharmaceutical Company entering top companies in India in the very few year of its launch.

  • The company is backed by a network of 7 world class manufacturing units and R & D facilities across India. The manufacturing facility is the one of the largest in Asia with, GMP, ISO9001, ISO 14001 certifications & USFDA approvable.
  • We have more than 100 innovative products in the pipeline across 8-10 therapeutic segments.
  • The Company is currently operating in the following segments Vascular surgery, Infertility management Obstetrics & Gynaecology Osteoporosis management Pain & Inflammation Management, Cardiology & geriatrics nutrition Gastroenterology.